Human Metabolome Technologies, Inc.

Research Human Metabolome Technologies, Inc. (6090.T) on Bullrun: market cap JPY 3.24B, P/E 17.1, dividend yield 3.0%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker6090.T
ExchangeTSE
CountryJapan
SectorHealthcare
IndustryDiagnostics & Research
CurrencyJPY
Market capJPY 3.24B
P/E17.1
Dividend yield3.0%
Financial periodFY2026
RevenueJPY 1.42B
Revenue growth-2.3%
Net incomeJPY 200.36M
Free cash flowJPY 125.21M
Gross margin61.1%

Valuation Snapshot

latest market cap is JPY 3.24B; P/E is 17.1; dividend yield is 3.0%.

Peer valuation comparison

Latest P/E is 17.07x versus a Healthcare sector median of 21.69x (21.3% below).

Latest dividend yield is 3.02% versus a Healthcare sector median of 2.41% (25.3% above).

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2026	JPY 1.42B	JPY 200.36M	JPY 125.21M	61.1%	n/a	JPY 1.44B	JPY 103.88M	JPY 1.83B
FY2025	JPY 1.46B	JPY 256.42M	JPY 224.79M	63.3%	43.67	JPY 1.56B	JPY 110.47M	JPY 1.91B
FY2024	JPY 1.35B	JPY 243.25M	JPY 202.70M	64.6%	41.14	JPY 1.79B	JPY 226.30M	JPY 1.95B
FY2023	JPY 1.30B	JPY 285.76M	JPY 168.11M	66.2%	48.39	JPY 1.66B	JPY 226.52M	JPY 1.77B
FY2022	n/a	n/a	n/a	n/a	45.39	n/a	n/a	n/a

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	JPY 3.24B	17.1	3.0%	18

Dividend history

Latest trailing dividend snapshot: annual dividend/share 18 JPY, yield 3.0%.

Year	Dividends/share
FY2026	18 JPY
FY2025	15 JPY
FY2024	15 JPY
FY2023	10 JPY

About Human Metabolome Technologies, Inc.

Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan. The company provides metabolome analysis services; and global profiling, targeted panels, flux analysis, and lipidomics services. The company offers solutions for cancer metabolism; metabolic flux analysis; functional food; neurobiology research; renal and disease markers; skin and dermo-metabolomics; T-cell and B-cell metabolism;

Related stock research

Japan stocks Japan Healthcare stocks A-Z stock index

Other Healthcare stocks

Shin Nippon Biomedical Laboratories, Ltd. (2395.T) Cosmo Bio Company,Limited (3386.T) H.U. Group Holdings, Inc. (4544.T) FALCO HOLDINGS Co., Ltd. (4671.T) BML, Inc. (4694.T) Veritas In Silico Inc. (130A.T) Kohjin Bio Co., Ltd. (177A.T) D & M Company Co., Ltd. (189A.T) Chordia Therapeutics Inc. (190A.T) WOLVES HAND Co., Ltd. (194A.T) TAUNS Laboratories,Inc. (197A.T) PRISM BioLab Co.,LTD (206A.T)

Frequently asked questions

What is Human Metabolome Technologies, Inc.'s market cap?

Human Metabolome Technologies, Inc.'s market capitalization is JPY 3.24B.

What is Human Metabolome Technologies, Inc.'s P/E ratio?

Human Metabolome Technologies, Inc.'s price-to-earnings (P/E) ratio is 17.1.

Does Human Metabolome Technologies, Inc. pay a dividend?

Human Metabolome Technologies, Inc. has a dividend yield of 3.0%.